Friday, Jan 02nd
Last update10:30:44 PM GMT
Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world.
 The Trump administration is facing a legal complaint from a group of government employees affected by... |
 Eileen Schoch traveled to her mother's funeral in Asheville, N.C. and found the hotel room —... | ||
 The Department of Health and Human Services is freezing all childcare payments to all states, an... |
 US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss... |
